Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. The Bridge Message Board

'Crazyshade' indeed. Scientific method smeshthod,

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 127632
(Total Views: 174)
Posted On: 04/21/2018 12:03:25 PM
Posted By: Bhawks
Re: Shady #11034
'Crazyshade' indeed. Scientific method smeshthod, if we could only bleed children. Or perhaps a concoction or a poultice administered to the words of a chant?

"Fillet of a fenny snake, In the cauldron boil and bake; Eye of newt and toe of frog, Wool of bat and tongue of dog, Adder's fork and blind-worm's sting, Lizard's leg and owlet's wing, For a charm of powerful trouble, Like a hell-broth boil and bubble."


Quote:
The 20 Most Frequent Objections to Vaccinations – and Responses by Immunisation Experts of the Robert Koch Institute and the Paul-Ehrlich-Institut

https://www.rki.de/EN/Content/Institute/Depar...onses.html

Date: 19.8.2016

1: The effectiveness of vaccinations has never been proven.

According to current pharmaceutical legislation, a vaccine is only licensed when it has been proven that it is effective and well-tolerated. The manufacturer must provide this proof by conducting pre-clinical tests and clinical trials. The results are checked at EU level by the European Medicines Agency (EMA). Within Germany, the Paul-Ehrlich-Institut carries responsibility in its role as Federal Institute for Vaccines and Biomedicines.

Moreover, once a vaccine has been licensed, further ongoing studies are conducted to monitor its effectiveness and safety. These studies are often undertaken by the manufacturers but also by independent scientists at universities and research institutes.

Consequently, the effectiveness and safety of vaccines that have been in use for decades, such as measles vaccines, have been demonstrated on millions of people. The fact that it has been possible to successfully reduce the occurrence of measles worldwide and avoid deaths is just one of the ways in which this effectiveness expresses itself.

Another well-known example is the introduction of oral polio vaccination at the beginning of the 1960s. Whilst in Germany in 1961, nearly 4,700 children suffered from polio, by 1965, the figure was down to fewer than 50. Since 1990, there have been no further cases of the disease caused by wild polio viruses (see also answer to Objection 17).

A similar impact was achieved by vaccinating against Haemophilus influenzae (Type B) bacterium which can cause meningitis in babies and toddlers. In the former German Democratic Republic (GDR), where all infection figures were registered very precisely, roughly 100 to 120 cases of meningitis occurred every year prior to 1990. After the introduction of Haemophilus vaccination throughout Germany in 1990, the annual number of cases in the eastern German federal states rapidly fell to fewer than ten annually.



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us